title: Guillain Barré syndrome, a possible side effect of buffy coat transfusion and IFN alpha therapy in relapsed CML after bone marrow transplantation.
authors.forename: A
authors.initials: A
authors.lastname: Schwarzer
authors.forename: E
authors.initials: E
authors.lastname: Schulze
authors.forename: S
authors.initials: S
authors.lastname: Leiblein
authors.forename: R
authors.initials: R
authors.lastname: Krahl
authors.forename: M
authors.initials: M
authors.lastname: Kubel
authors.forename: C
authors.initials: C
authors.lastname: Bartram
authors.forename: J
authors.initials: J
authors.lastname: Edelmann
authors.forename: U
authors.initials: U
authors.lastname: Sack
authors.forename: W
authors.initials: W
authors.lastname: Helbig
mesh_terms: D000328:Adult; D016913:Blood Component Transfusion / Q000009:adverse effects*; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D003131:Combined Modality Therapy / Q000009:adverse effects; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D008297:Male; D011129:Polyradiculoneuropathy / Q000175:diagnosis / Q000209:etiology*; D012008:Recurrence
chemical_list: D016898:Interferon-alpha